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Abstract
Background: stroke is the main cause of disability in high-income countries, and ranks second as a cause of death
worldwide. Patients with acute stroke are at risk for infections, but reported post-stroke infection rates vary
considerably. We performed a systematic review and meta-analysis to estimate the pooled post-stroke infection
rate and its effect on outcome.
Methods: MEDLINE and EMBASE were searched for studies on post-stroke infection. Cohort studies and
randomized clinical trials were included when post-stroke infection rate was reported. Rates of infection were
pooled after assessment of heterogeneity. Associations between population- and study characteristics and infection
rates were quantified. Finally, we reviewed the association between infection and outcome.
Results: 87 studies were included involving 137817 patients. 8 studies were restricted to patients admitted on the
intensive care unit (ICU). There was significant heterogeneity between studies (P < 0.001, I
2 = 97%). The overall
pooled infection rate was 30% (24-36%); rates of pneumonia and urinary tract infection were 10% (95% confidence
interval [CI] 9-10%) and 10% (95%CI 9-12%). For ICU studies, these rates were substantially higher with 45% (95% CI
38-52%), 28% (95%CI 18-38%) and 20% (95%CI 0-40%). Rates of pneumonia were higher in studies that specifically
evaluated infections and in consecutive studies. Studies including older patients or more females reported higher
rates of urinary tract infection. Pneumonia was significantly associated with death (odds ratio 3.62 (95%CI 2.80-4.68).
Conclusions: Infection complicated acute stroke in 30% of patients. Rates of pneumonia and urinary tract infection
after stroke were 10%. Pneumonia was associated with death. Our study stresses the need to prevent infections in
patients with stroke.
Background
Infection is a common complication in the acute phase
after stroke. Reported infection rates after stroke vary
considerably, ranging 5-65%. Differences in patient
populations, study design and definition of infection
may account for these large variations in post stroke
infection rates [1]. However, a reliable pooled estimate
of the infection rate in patients with stroke is lacking.
Pneumonia is the most common post-stroke infection
and been associated with a relative risk of 3.0 for mor-
tality in a study including 14293 patients with stroke [2].
Consequently, new treatment strategies, i.e.p r e v e n t i v e
antibiotics, are currently under investigation [3]. In this
systematic review and meta-analysis we calculated the
pooled post-stroke infection rates, identified study and
population characteristics associated with infection, and
estimated the impact of pneumonia on outcome after
stroke.
Methods
Selection of studies
Cohort studies and randomized clinical trials (RCT) on
ischemic or hemorrhagic stroke with reported rates of
infections in the acute phase were included. In- and
exclusion criteria are listed in Additional File 1: Table
S1. A literature search in MEDLINE (1950 to present)
and EMBASE (1980 to present) was performed without
language restrictions (Additional File 1: Table S2). Cross
references were checked and experts in the field were
consulted. Infection was defined according to the cri-
teria used in included studies. Studies including a small
subgroup of patients, i.e., those restricted to patients
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If two publications described one similar patient group
data was used only once; this occurred three times [4-9].
If studies reported data of different treatment arms sepa-
rately, these were also included as separate groups in our
analysis [10,11]. Treatment arms in randomized con-
trolled trials on preventivea n t i b i o t i ct h e r a p yw e r e
excluded, since this is likely to influence infection rate
and is not part of standard stroke care [12].
Data extraction
Two independent observers (WFW and JDV) extracted
data from selected articles according to predefined defi-
nitions. Disagreement was resolved by discussion.
Overall infection rate and rate of pneumonia and urin-
ary tract infection - the most common post-stroke infec-
tions - were extracted [13]. When percentages were
given, these were converted into absolute numbers. We
did not calculate an overall infection rate in each study
by adding data on different infections, because of the
possibility of two infections occurring in one patient.
We also extracted the study characteristics prospective
design, consecutive enrollment, type of stroke, study aim
on infection and observation period. Population character-
istics extracted were income country, age, gender, ICU
study, infarction or bleeding, stroke severity, lowered con-
sciousness, dysphagia and urinary incontinence/retention.
Definitions can be found in Additional File 1: Table S3.
Analyses
For each study we calculated the proportion of overall
infection, pneumonia and urinary tract infection. Next,
these proportions were pooled using Review Manager to
obtain one estimate for each infection. A fixed or random
effects model was chosen after tests of heterogeneity (het-
erogeneity was defined with p-value < 0.05). Subgroup
analysis was performed on Intensive Care Unit (ICU) vs.
non-ICU studies. Subsequently, we performed univariate
analyses investigating the association between population
and study characteristics and the pooled proportion of
infection, pneumonia and urinary tract infection. Pearson
or Spearman correlation, Students T-Test, Mann-Whitney
U Test or 1-way ANOVA were used when appropriate.
Characteristics with a p-value < 0.10 were included in a
multivariate regression analysis. To transform the propor-
tion of pneumonia and urinary tract infection in a nor-
mally distributed variable we used arc sin-square root and
square root transformations. Review Manager 5 and SPSS
(version 16.0) were used for the statistical analyses.
Results
Included studies
Figure 1 summarizes the study selection process. 87 stu-
dies were included involving 137817 patients. 8 studies
included patients admitted on the ICU and 79 studies
included patients admitted on stroke-unit, medium care
facility or ward (non-ICU studies). Reasons for exclusion
are noted in Additional File 1: Table S4. Not all character-
istics could be extracted from all studies: age was reported
in 77 studies; gender in 80; observation period in 73;
stroke severity in 21; lowered consciousness in 25; urinary
incontinence/retention in 6; and dysphagia in 26 studies.
All extracted data is shown Additional File 2: Table S1.
Pooled infection rates
Infection rates were evaluated in all 87 studies (Table 1).
Pooled values were calculated in a random effects model
because of significant heterogeneity between studies (P
< 0.001, I
2 = 97%). The overall pooled infection rate was
30% (95%CI 24-36%). The pooled pneumonia rate was
10% (95%CI 9-10%) and of urinary tract infection 10%
(95%CI 9-12%). In ICU studies, overall infection rate
was 45% (95%CI 38-52%) and rates of pneumonia and
urinary tract infection were 28% (95%CI 18-38%) and
20% (95%CI 0-40%). In non-ICU studies, overall infec-
tion rate was 28% (95%CI 22-34%) and rates of pneumo-
nia and urinary tract infection were 9% (95%CI 9-10%)
and 10% (95%CI 8-11%).
Records identified 
through MEDLINE 
(1950 to present) 
searching
(n = 2587)
Records identified 
through EMBASE 
(1980 to present) 
searching 
(n = 2963)
Records with titles 
and abstracts 
screened (n = 130)
Records with titles 
and abstracts 
screened (n = 60)
Records after 
duplicates removed 
(n = 143)
Screening full-text 
articles (n = 87)
Studies included in 
meta-analyses 
(n = 87)
Full text 
articles
excluded
(n = 56)
Figure 1 Flowchart of study selection.
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Associations between population and study characteris-
tics with infection rates are noted in Table 2 and 3. In
univariate analysis, infection rate was higher in ICU-stu-
dies (P = 0.05) and in studies with a longer observation
period (P = 0.03); a trend towards significance was seen
for lowered consciousness (P=0 . 0 6 ) .W ed i dn o tp e r -
form multivariate analysis for infection, because few stu-
dies reported all 3 variables. In the subgroup of non-
ICU studies, an even stronger association was seen for
observation period (P = 0.003).
The rate of pneumonia was higher in ICU studies (P =
0.001), prospective studies (P = 0.02), studies that speci-
fically evaluated infections (P = 0.004), studies with con-
secutive enrollment (P = 0.005), studies with a higher
stroke severity (P = 0.01) and studies with higher pro-
portions of patients with a lowered consciousness (P =
0.001). Stroke severity was closely related to ICU-study
(Mann-Whitney U, Z -2,154, P = 0.02). In multivariate
analysis pneumonia rate was associated with study
characteristics: ICU studies (B 0.207, standard error (se)
0.042, P <0.01), study aim on infection (B 0.062, se
0.026, P = 0.02), consecutive enrollment (B 0.058, se
0.024, P = 0.02). Stroke severity and lowered conscious-
ness were excluded from this multivariate analysis since
these characteristics were only reported in a relatively
small number of studies. In non-ICU studies, rate of
pneumonia was also higher in studies that specifically
evaluated infections (B 0.06, se 0.025, P = 0.02) and stu-
dies with consecutive enrollment (B 0.065, se 0.022, P =
0.005)i nm u l t i v a r i a t ea n a l y s i s. No associations were
found between age (P = 0.18) or dysphagia (P = 0.16)
and pneumonia rate.
The rate of urinary tract infections was higher in stu-
dies with a higher stroke severity (P = 0.01),al o w e r
proportion of male patients (P = 0.005), prospective stu-
dies (P = 0.02) and in studies with a longer observation
period (P = 0.10). A trend towards significance was seen
for studies with a higher mean age (P = 0.08).I nm u l t i -
variate analysis, advanced age was independently
Table 1 Pooled infection rates in 137817 patients with stroke
All studies ICU studies Non-ICU studies
No. of included studies 87 8 79
No. of evaluated patients 137817 871 136946
Infection rates % (95%CI) % (95%CI) % (95%CI)
All infections 30 (24-36) 45% (38-52%) 28% (22-34%)
Pneumonia 10 (9-10) 28% (18-38%) 9% (9-10%)
Urinary tract infection 10 (9-12) 20% (0-40%) 10% (8-11%)
Footnote Table 1: CI denotes confidence interval
Table 2 Univariate analysis between study or population
characteristics and reported infection rates
Study/population
characteristic*
No. of
studies
No. of evaluated
patients
P-
value
Study design
Prospective design 18 9174 0.82
Consecutive
enrollment
18 9174 0.42
Study aim on infection 18 9174 0.89
Observation period 17 8844 0.03
Population characteristics
Income country 18 9174 0.94
Age 18 9174 0.35
Gender 18 9174 0.86
ICU population 18 9174 0.05
Infarction of bleeding 18 9174 0.15
Stroke severity (NIHSS) 5 1818 0.14
Lowered
consciousness
6 2365 0.06
Dysphagia 6 395 0.97
Footnote Table 2: definitions of characteristics can be found in Additional File
1: Table S3
Table 3 Univariate analysis between study or population
characteristics and reported pneumonia rates
Study/population
characteristic*
No. of
studies
No. of evaluated
patients
P-
value
Study design
Prospective design 87 137779 0.02
Consecutive
enrollment
87 137779 0.005
Study aim on infection 87 137779 0.004
Observation period 73 102280 0.37
Population characteristics
Income country 87 137779 0.23
Age 77 118755 0.30
Gender 80 132750 0.76
ICU population 87 137779 0.001
Infarction of bleeding 87 137779 0.13
Stroke severity (NIHSS) 20 31493 0.01
Lowered
consciousness
25 52939 0.001
Dysphagia 26 17937 0.19
Footnotes Table 3: *definitions of characteristics can be found in Additional
File 1: Table S3
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Page 3 of 7associated with urinary tract infection (B 0.008, se 0.004,
P = 0.04). Gender was associated with urinary tract
infection, but only in a sub analysis of non-ICU studies
(B -0,341, se 0.164, P = 0.04).
Outcome
To estimate the effect of post-stroke infection on out-
come we pooled the mortality rates in patients with and
without infection of the studies reporting these rates. Of
all patients with an infection, 48% died vs. 18% of
patients without infection (N = 1839; OR 2.08, 95% CI
1.63 - 2.67). Mortality rates were also higher in patients
with pneumonia (26% vs. 5%, N = 16433; OR 5.58, 95%
CI 4.76, 6.55) and a little higher in patients with urinary
tract infection (12% vs. 10%, N = 2528; OR 1.12, 95% CI
0.76, 1.66). Since this data was not corrected for poten-
tial confounders, we also estimated the effect of pneu-
monia on death by pooling corrected odds ratios (OR)
in a random effects model. This meta-analysis included
four studies (19971 patients) and resulted in an OR in-
hospital mortality of 3.62 (95% CI 2.80-4.68) (Figure 2).
Five studies reported corrected OR of pneumonia for
unfavorable outcome (Table 4); meta-analysis was not
performed because of differences in outcome measure
and follow-up. These studies showed an increased risk
of unfavorable outcome in post-stroke patients with
pneumonia. Urinary tract infection had no association
with death according to four studies reporting on this
[14-17]. Three studies evaluated the effect on functional
outcome for urinary tract infection, two studies showed
an association with poor outcome in multivariate analy-
sis [14,18,19]. OR’s for unfavorable functional outcome
were 2.72 (95% CI 4.73-11.84) and 3.1 (95% CI 1.6-5.9).
Discussion
This meta-analysis shows that infections commonly
complicate the acute phase after stroke. The pooled
overall infection rate was 30% and pneumonia and urin-
ary tract infections occurred each in 10% of patients.
Previous studies showed a wide range of post-stroke
infection rates, from 5%- 65% for infections, 1%-33% for
pneumonia, and 2%-27% for urinary tract infection
[1,20]. This meta-analysis included a large number of
patients and therefore provides a reliable estimate of
infection after stroke.
We identified several study and population character-
istics that were associated with infection rate. Given the
prevalence of pneumonia and urinary tract infection in
general wards in Dutch hospitals - 1.1% and 1.7%
respectively - our findings confirm that infection rate in
patients in the acute phase of stroke is high [21]. This
increased vulnerability of patients in the acute phase of
stroke for infections can be attributed to different
factors.
First, infection was associated with study characteris-
tics. Studies aimed on infection and those with consecu-
tive enrolment were associated with higher infection
rate. Possibly, these studies benefit of more rigorous
detection of infection. Rate of infection was also higher
in studies with a longer observation time. In a prospec-
tive observational study, most post stroke infections
occurred within three days of hospital admission [1].
Nevertheless, 25% of infections occurred after these
three days. Also, most urinary tract infections occur
after 48 hours, i.e. most UTI’s are hospital acquired, and
therefore it seems logical that a longer observation time
yielded a higher urinary tract infection rate in our study
[17]. The absence of an association between observation
time and pneumonia is not surprising. Pneumonia is
mostly diagnosed within the first days following a
stroke, both in studies performed on general wards as
well as ICU’s [1,13,22-24].
Microbiologic data of patients with post-stroke pneu-
monia shows a pattern of mostly early onset nosocomial
pneumonia, or a community acquired aspiration syn-
drome. Staphylococcus aureus and gram-negative bac-
teria such as Klebsiella pneumoniae, Pseudomonas
aeruginosa, Escherichia coli or Enterobacter spp.w e r e
commonly identified; also Streptococcus species are occa-
sionally found. Gram-negative bacteria and Staphylococ-
cus aureus are known to cause pneumonia by aspiration
of endogenous material from the colonized oropharynx
Figure 2 Pooled odds ratios: effect of pneumonia on in-hospital mortality.
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infections [27]. Streptococcus species is still the most
detected pathogen in community acquired pneumonia
[28]. In stroke patients, it could be a cause of ‘commu-
nity acquired aspiration pneumonia’, with aspiration
occurring at the stroke ictus [29]. Often, no causative
organism is detected in post-stroke pneumonia. Yield of
cultures is usually not very high in patients with pneu-
monia; collection of material could be even more diffi-
cult in stroke patients due to neurologic deficit or
lowered level of consciousness. Also, some cases of sus-
pected pneumonia could in fact be a non-infectious
aspiration pneumonitis, or the infection could be caused
by anaerobic bacteria that require special culturing tech-
niques. However, the role of anaerobic bacteria in the
development of pneumonia is unclear [29,30].
Second, infection rate was associated with the patients’
clinical condition. Studies including patients with a
higher stroke severity or lower levels of consciousness
showed higher infection rates, in particular for pneumo-
nia. This effect corresponds with previous studies that
often report both characteristics as risk factors for pneu-
monia [14,31,32]. Risk for aspiration is increased in
these patients due to the absence of protective reflexes,
and this risk is related to the degree of consciousness
impairment [33]. Most stroke related pneumonias are
believed to result from dysphagia and subsequent aspira-
tion of oropharyngeal material or gastric content. A sys-
tematic review by Martino et al showed that dysphagia
occurs in 37- 78% of stroke patients and increases the
risk for pneumonia 3-fold and 11-fold in patients with
confirmed aspiration [34]. However, up to half of
patients with post stroke pneumonia do not aspirate,
which implies that also other mechanisms are involved,
e.g., stroke-induced immunodepression which is dis-
cussed below [2].
We also found higher infection rates in ICU studies.
Patients admitted to an ICU generally suffer from more
severe strokes and also the frequency of invasive proce-
dures is higher [15,24,32,35]. The use of invasive proce-
dures - i.e. urinary catheterization or mechanical
ventilation in ICU patients - increase infection risk by
facilitating the entry of a pathogen [17,35].
We identified a higher age and female sex as risk fac-
tors for urinary tract infection. Both of these character-
istics have previously been reported as risk factors for
urinary tract infection [16,17]. Studies frequently report
urinary catheterization as an important risk factor; we
could not investigate this association because this char-
acteristic was mostly not reported [17]. Advanced age as
risk factor for post-stroke infection has been reported
previously [16].
In addition to above mentioned characteristics, acute
stroke may lead to stroke-induced immunodepression, a
systemic anti-inflammatory response that is related to
susceptibility to infection [20,36,37]. This anti-inflamma-
tory response was found in different clinical studies in
acute stroke patients, and includes an excessive counter-
inflammatory cytokine responses and impairments in
cell-mediated immunity [38]. Certain features of this
response - i.e., reduced lymphocyte count, delay in the
recovery of T-lymphocyte loss - were more pronounced
in patients developing post stroke infections [37,39].
These results suggest that immunological changes could
facilitate infection in acute stroke.
Outcome is affected by post-stroke infections, as
s h o w ni no u rr e v i e w .P n e u m o n i aa n du r i n a r yt r a c t
infection both increase the risk for unfavorable outcome
and pneumonia is associated with mortality with an OR
of 3.62. Infections could affect outcome in several ways.
Firstly, they lead to immobilization, general frailty and a
delay in rehabilitation due to prolonged hospital stay
[1,40]. More importantly, immunological effects of infec-
tions could worsen outcome. Evidence from experimen-
tal studies suggests that infection promotes antigen
presentation and autoimmunity against the brain [41].
However, the evidence on this topic is scarce and the
exact pathofysiology remains to be investigated.
Our systematic review has limitations. First, results are
limited by publication bias. Data was derived from ran-
domized controlled trials, cohort studies and stroke
registries; infection rate could differ in hospitals without
stroke research or complication registries. Second,
included studies were heterogeneous in definition of
infection, which was based on clinical grounds and in
some cases not described. A standardized definition for
Table 4 Effect of pneumonia on functional outcome
Study No. of patients Outcome
(modified Rankin Scale)
OR
(95% CI)
Correction for
confounders
Vermeij et al [1] 521 > 2 at discharge
> 2 at 1 year
9.5 (1.7-52)
10.95 (2.2-46)
Yes
Hong et al [18] 1254 3-6 at 3 months 4.44 (2.20-8.99) Yes
Huang et al [46] 66 < 3 at 1 month 0.50 (0.38-0.64) No
Ovbiagele [16] 663 0-3 at discharge 0.16 (0.09-0.29) Yes
Aslanyan et al [14] 1455 ≥ 2 at 3 months 3.4 (1.4-8.3) Yes
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trol and Prevention [42] - is preferred since stricter cri-
teria could permit identification of fewer infections.
Next, not all relevant characteristics - for example use
of antibiotics, differences in primary stroke care or use
of a urinary catheter - could be evaluated, due to lack of
data in included studies. Some of these characteristics
have previously been described as a risk factor for infec-
tion and could have confounded our results. Thirdly, for
some characteristics data was lacking in many studies.
Surprisingly, no association was found between age or
dysphagia and pneumonia rate, often described risk fac-
tors for pneumonia [24,31,32,35,43,44]. Dysphagia was
n o tr e p o r t e di na l ls t u d i e s ,which was a limiting factor
in the analysis. Lack of these significant associations
could be due to few studies reporting adequate informa-
tion on all these characteristics and therefore the ana-
lyses have low explanatory power. Finally, many of the
characteristics act on patient level, but studies report
aggregate data (i.e., mean age of study population) also
reducing explanatory power. Due to these limitations -
most importantly the heterogeneity in definition of
infections - results of this review need to be interpreted
with caution.
Our review shows the potential of strategies aiming to
prevent infections in patients with stroke. Some of these
strategies - i.e., prevention of aspiration and reduction of
urinary catheterisation - are incorporated in stroke unit
care, which reduces the risk of death after stroke through
the prevention of infections in particular [45]. Infections
can also be prevented by use of preventive antibiotic
therapy, as shown in a recent meta-analysis. This meta-
analysis did not establish a reduction in mortality, how-
ever, included studies were small and heterogeneous and
functional outcome was not evaluated [12]. Also, limited
data was reported on the effect on antibiotic resistance.
Currently, the use of preventive antibiotics in stroke, and
the effect of this therapy on antibiotic resistance, is inves-
tigated in a large randomized controlled trial with func-
tional endpoint [3]. This trial will be able to establish
whether preventive antibiotic treatment is an effective
strategy to prevent infection and its adverse effect on
outcome in patients in the acute phase of stroke.
Conclusions
Results of this meta-analysis show an overall infection
rate in the acute phase of stroke of 30%. Rates of pneu-
monia and urinary tract infection were both 10%. Infec-
tion rates are related with study characteristics and the
patients’ clinical condition, e.g., age, gender, stroke
severity, level of consciousness and whether a patient is
admitted on ICU. Pneumonia is an independent risk fac-
tor for unfavorable outcome and death after stroke. Our
data stress the need of interventions to prevent infec-
tions in patients with stroke.
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